Global Nucleic Acid Based Gene Therapy Market Research Report 2024(Status and Outlook)

Global Nucleic Acid Based Gene Therapy Market Research Report 2024(Status and Outlook)



Report Overview:

Gene therapy is used for correcting defective genes that are responsible for disease development. Moreover, nucleic acid-based therapeutics are used to treat genetic disorders and diseases for which there exists no permanent cure such as anaemia, sickle cell, cystic fibrosis, diabetes, and thalassemia.

The Global Nucleic Acid Based Gene Therapy Market Size was estimated at USD 4974.44 million in 2023 and is projected to reach USD 8764.57 million by 2029, exhibiting a CAGR of 9.90% during the forecast period.

This report provides a deep insight into the global Nucleic Acid Based Gene Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Nucleic Acid Based Gene Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Nucleic Acid Based Gene Therapy market in any manner.

Global Nucleic Acid Based Gene Therapy Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Wave Life Sciences

Imugene

Sarepta Therapeutics

Alnylam Pharmaceuticals

Ionis Pharmaceuticals

Moderna

BioNTech

Nutcracker Therapeutics

Deep Genomics

Sirnaomics

Laronde

Abogen Biosciences

Market Segmentation (by Type)

Anti-Sence and Anti-Gene

Short Inhibitory Sequences

Gene Transfer Therapy

Nucleoside Analogs

Ribozymes

Aptamers

Others

Market Segmentation (by Application)

Hospitals and Clinics

Academic and Research Institutes

Others

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Nucleic Acid Based Gene Therapy Market
  • Overview of the regional outlook of the Nucleic Acid Based Gene Therapy Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nucleic Acid Based Gene Therapy Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Nucleic Acid Based Gene Therapy
1.2 Key Market Segments
1.2.1 Nucleic Acid Based Gene Therapy Segment by Type
1.2.2 Nucleic Acid Based Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Nucleic Acid Based Gene Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Nucleic Acid Based Gene Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Nucleic Acid Based Gene Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Nucleic Acid Based Gene Therapy Market Competitive Landscape
3.1 Global Nucleic Acid Based Gene Therapy Sales by Manufacturers (2019-2024)
3.2 Global Nucleic Acid Based Gene Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Nucleic Acid Based Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Nucleic Acid Based Gene Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Nucleic Acid Based Gene Therapy Sales Sites, Area Served, Product Type
3.6 Nucleic Acid Based Gene Therapy Market Competitive Situation and Trends
3.6.1 Nucleic Acid Based Gene Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Nucleic Acid Based Gene Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Nucleic Acid Based Gene Therapy Industry Chain Analysis
4.1 Nucleic Acid Based Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Nucleic Acid Based Gene Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Nucleic Acid Based Gene Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nucleic Acid Based Gene Therapy Sales Market Share by Type (2019-2024)
6.3 Global Nucleic Acid Based Gene Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Nucleic Acid Based Gene Therapy Price by Type (2019-2024)
7 Nucleic Acid Based Gene Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nucleic Acid Based Gene Therapy Market Sales by Application (2019-2024)
7.3 Global Nucleic Acid Based Gene Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Nucleic Acid Based Gene Therapy Sales Growth Rate by Application (2019-2024)
8 Nucleic Acid Based Gene Therapy Market Segmentation by Region
8.1 Global Nucleic Acid Based Gene Therapy Sales by Region
8.1.1 Global Nucleic Acid Based Gene Therapy Sales by Region
8.1.2 Global Nucleic Acid Based Gene Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Nucleic Acid Based Gene Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Nucleic Acid Based Gene Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Nucleic Acid Based Gene Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Nucleic Acid Based Gene Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Nucleic Acid Based Gene Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Wave Life Sciences
9.1.1 Wave Life Sciences Nucleic Acid Based Gene Therapy Basic Information
9.1.2 Wave Life Sciences Nucleic Acid Based Gene Therapy Product Overview
9.1.3 Wave Life Sciences Nucleic Acid Based Gene Therapy Product Market Performance
9.1.4 Wave Life Sciences Business Overview
9.1.5 Wave Life Sciences Nucleic Acid Based Gene Therapy SWOT Analysis
9.1.6 Wave Life Sciences Recent Developments
9.2 Imugene
9.2.1 Imugene Nucleic Acid Based Gene Therapy Basic Information
9.2.2 Imugene Nucleic Acid Based Gene Therapy Product Overview
9.2.3 Imugene Nucleic Acid Based Gene Therapy Product Market Performance
9.2.4 Imugene Business Overview
9.2.5 Imugene Nucleic Acid Based Gene Therapy SWOT Analysis
9.2.6 Imugene Recent Developments
9.3 Sarepta Therapeutics
9.3.1 Sarepta Therapeutics Nucleic Acid Based Gene Therapy Basic Information
9.3.2 Sarepta Therapeutics Nucleic Acid Based Gene Therapy Product Overview
9.3.3 Sarepta Therapeutics Nucleic Acid Based Gene Therapy Product Market Performance
9.3.4 Sarepta Therapeutics Nucleic Acid Based Gene Therapy SWOT Analysis
9.3.5 Sarepta Therapeutics Business Overview
9.3.6 Sarepta Therapeutics Recent Developments
9.4 Alnylam Pharmaceuticals
9.4.1 Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Basic Information
9.4.2 Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Product Overview
9.4.3 Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Product Market Performance
9.4.4 Alnylam Pharmaceuticals Business Overview
9.4.5 Alnylam Pharmaceuticals Recent Developments
9.5 Ionis Pharmaceuticals
9.5.1 Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Basic Information
9.5.2 Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Product Overview
9.5.3 Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Product Market Performance
9.5.4 Ionis Pharmaceuticals Business Overview
9.5.5 Ionis Pharmaceuticals Recent Developments
9.6 Moderna
9.6.1 Moderna Nucleic Acid Based Gene Therapy Basic Information
9.6.2 Moderna Nucleic Acid Based Gene Therapy Product Overview
9.6.3 Moderna Nucleic Acid Based Gene Therapy Product Market Performance
9.6.4 Moderna Business Overview
9.6.5 Moderna Recent Developments
9.7 BioNTech
9.7.1 BioNTech Nucleic Acid Based Gene Therapy Basic Information
9.7.2 BioNTech Nucleic Acid Based Gene Therapy Product Overview
9.7.3 BioNTech Nucleic Acid Based Gene Therapy Product Market Performance
9.7.4 BioNTech Business Overview
9.7.5 BioNTech Recent Developments
9.8 Nutcracker Therapeutics
9.8.1 Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Basic Information
9.8.2 Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Product Overview
9.8.3 Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Product Market Performance
9.8.4 Nutcracker Therapeutics Business Overview
9.8.5 Nutcracker Therapeutics Recent Developments
9.9 Deep Genomics
9.9.1 Deep Genomics Nucleic Acid Based Gene Therapy Basic Information
9.9.2 Deep Genomics Nucleic Acid Based Gene Therapy Product Overview
9.9.3 Deep Genomics Nucleic Acid Based Gene Therapy Product Market Performance
9.9.4 Deep Genomics Business Overview
9.9.5 Deep Genomics Recent Developments
9.10 Sirnaomics
9.10.1 Sirnaomics Nucleic Acid Based Gene Therapy Basic Information
9.10.2 Sirnaomics Nucleic Acid Based Gene Therapy Product Overview
9.10.3 Sirnaomics Nucleic Acid Based Gene Therapy Product Market Performance
9.10.4 Sirnaomics Business Overview
9.10.5 Sirnaomics Recent Developments
9.11 Laronde
9.11.1 Laronde Nucleic Acid Based Gene Therapy Basic Information
9.11.2 Laronde Nucleic Acid Based Gene Therapy Product Overview
9.11.3 Laronde Nucleic Acid Based Gene Therapy Product Market Performance
9.11.4 Laronde Business Overview
9.11.5 Laronde Recent Developments
9.12 Abogen Biosciences
9.12.1 Abogen Biosciences Nucleic Acid Based Gene Therapy Basic Information
9.12.2 Abogen Biosciences Nucleic Acid Based Gene Therapy Product Overview
9.12.3 Abogen Biosciences Nucleic Acid Based Gene Therapy Product Market Performance
9.12.4 Abogen Biosciences Business Overview
9.12.5 Abogen Biosciences Recent Developments
10 Nucleic Acid Based Gene Therapy Market Forecast by Region
10.1 Global Nucleic Acid Based Gene Therapy Market Size Forecast
10.2 Global Nucleic Acid Based Gene Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Nucleic Acid Based Gene Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Nucleic Acid Based Gene Therapy Market Size Forecast by Region
10.2.4 South America Nucleic Acid Based Gene Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Nucleic Acid Based Gene Therapy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Nucleic Acid Based Gene Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Nucleic Acid Based Gene Therapy by Type (2025-2030)
11.1.2 Global Nucleic Acid Based Gene Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Nucleic Acid Based Gene Therapy by Type (2025-2030)
11.2 Global Nucleic Acid Based Gene Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Nucleic Acid Based Gene Therapy Sales (Kilotons) Forecast by Application
11.2.2 Global Nucleic Acid Based Gene Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings